Growth Metrics

Erasca (ERAS) Shares Outstanding (Diluted Average) (2021 - 2026)

Erasca posted quarterly Shares Outstanding (Diluted Average) of $304.3 million for Q1 2026, up 7.43% year-on-year from $283.3 million in Q1 2025, and up 7.33% on a QoQ basis from $283.5 million in Q4 2025.

Erasca (ERAS) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $304.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 7.43% year-over-year to $304.3 million; the trailing twelve-month figure through Mar 2026 stood at $304.3 million (up 7.43% YoY), and the FY2025 full-year result was $283.5 million, up 21.26% from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 stood at $304.3 million, up from $283.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $304.3 million in Q1 2026 and bottomed at $119.5 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $151.2 million (2024), against an average of $196.5 million.
  • The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) surged 410.46%; it then advanced 1.11% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $122.0 million in 2022, then rose by 23.08% to $150.2 million in 2023, then soared by 55.69% to $233.8 million in 2024, then advanced by 21.26% to $283.5 million in 2025, then rose by 7.33% to $304.3 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $304.3 million (Q1 2026), $283.5 million (Q4 2025), and $283.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 810.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 256.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 138.23 Mn
10 Erasca 4.21 Bn 3.97 Bn - 304.32 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 304.32 Mn
Dec 31, 2025 283.53 Mn
Sep 30, 2025 283.43 Mn
Jun 30, 2025 283.36 Mn
Mar 31, 2025 283.26 Mn
Dec 31, 2024 233.82 Mn
Sep 30, 2024 217.36 Mn
Jun 30, 2024 217.81 Mn
Mar 31, 2024 151.16 Mn
Dec 31, 2023 150.18 Mn
Sep 30, 2023 150.45 Mn
Jun 30, 2023 149.77 Mn
Mar 31, 2023 149.50 Mn
Dec 31, 2022 122.02 Mn
Sep 30, 2022 120.17 Mn
Jun 30, 2022 120.19 Mn
Mar 31, 2022 119.49 Mn
Dec 31, 2021 66.29 Mn
Sep 30, 2021 48.58 Mn
Jun 30, 2021 23.55 Mn